[{"Assets_0_Q1_USD":2153700000.0,"CommonStockSharesOutstanding_0_Q1_shares":51400000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":104800000.0,"NetIncomeLoss_1_Q1_USD":-26000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":51224125.0,"EarningsPerShareBasic_1_Q1_USD":-0.51,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190508"}]